BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 28438887)

  • 1. A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.
    Crona DJ; Faso A; Nishijima TF; McGraw KA; Galsky MD; Milowsky MI
    Oncologist; 2017 May; 22(5):609-619. PubMed ID: 28438887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity: Evidence in Patients Receiving Cisplatin Therapy.
    Duffy EA; Fitzgerald W; Boyle K; Rohatgi R
    Clin J Oncol Nurs; 2018 Apr; 22(2):175-183. PubMed ID: 29547601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydration Methods for Cisplatin Containing Chemotherapy: A Systematic Review.
    Sikking C; Niggebrugge-Mentink KL; van der Sman ASE; Smit RHP; Bouman-Wammes EW; Beex-Oosterhuis MM; van Kesteren C
    Oncologist; 2024 Feb; 29(2):e173-e186. PubMed ID: 37995306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephropathy in Patients Undergoing Cancer Drug Therapy - Platinum Derivatives(Cisplatin and Carboplatin)].
    Matsuoka A; Ando Y
    Gan To Kagaku Ryoho; 2017 Mar; 44(3):200-203. PubMed ID: 28292990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy.
    Morgan KP; Buie LW; Savage SW
    Ann Pharmacother; 2012 Feb; 46(2):276-81. PubMed ID: 22298599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-Pharmacodynamic Analysis of Cisplatin with Hydration and Mannitol Diuresis: The Contribution of Urine Cisplatin Concentration to Nephrotoxicity.
    Fukushima K; Okada A; Oe H; Hirasaki M; Hamori M; Nishimura A; Shibata N; Sugioka N
    Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):193-203. PubMed ID: 28913815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
    Ruggiero A; Rizzo D; Trombatore G; Maurizi P; Riccardi R
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):19-26. PubMed ID: 26589789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannitol for the prevention of cisplatin-induced nephrotoxicity: A retrospective comparison of hydration plus mannitol versus hydration alone in inpatient and outpatient regimens at a large academic medical center.
    Williams RP; Ferlas BW; Morales PC; Kurtzweil AJ
    J Oncol Pharm Pract; 2017 Sep; 23(6):422-428. PubMed ID: 27352615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.
    Hase T; Miyazaki M; Ichikawa K; Yogo N; Ozawa N; Hatta T; Ando M; Sato M; Kondo M; Yamada K; Hasegawa Y
    Int J Clin Oncol; 2020 Nov; 25(11):1928-1935. PubMed ID: 32740717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.
    Yamamoto Y; Watanabe K; Tsukiyama I; Yabushita H; Matsuura K; Wakatsuki A
    Anticancer Res; 2016 Apr; 36(4):1873-7. PubMed ID: 27069173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cisplatin-induced nephrotoxicity when using conventional versus short hydration in gastric cancer-a retrospective study.
    Aoyama T; Tsunoda T; Kato H; Hagino A; Furutani R; Ito K; Yoshioka H; Nakamura M; Hiraide M; Kawakami K; Kobayashi K; Suzuki K; Ichimura T; Yamaguchi K; Hama T
    J Chemother; 2020 May; 32(3):144-150. PubMed ID: 31960769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy.
    McKibbin T; Cheng LL; Kim S; Steuer CE; Owonikoko TK; Khuri FR; Shin DM; Saba NF
    Support Care Cancer; 2016 Apr; 24(4):1789-93. PubMed ID: 26446698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short hydration regimen with magnesium supplementation prevents cisplatin-induced nephrotoxicity in lung cancer: a retrospective analysis.
    Yamaguchi T; Uozu S; Isogai S; Hayashi M; Goto Y; Nakanishi T; Imaizumi K
    Support Care Cancer; 2017 Apr; 25(4):1215-1220. PubMed ID: 27966021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study.
    Oka T; Kimura T; Suzumura T; Yoshimoto N; Nakai T; Yamamoto N; Matsuura K; Mitsuoka S; Yoshimura N; Kudoh S; Hirata K
    BMC Pharmacol Toxicol; 2014 Dec; 15():70. PubMed ID: 25472655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
    Morgan KP; Snavely AC; Wind LS; Buie LW; Grilley-Olson J; Walko CM; Weiss J
    Ann Pharmacother; 2014 Jul; 48(7):863-869. PubMed ID: 24778426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Sainamthip P; Saichaemchan S; Satirapoj B; Prasongsook N
    JCO Glob Oncol; 2022 Mar; 8():e2100275. PubMed ID: 35436142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review for prevention of cisplatin-induced nephrotoxicity using different hydration protocols and meta-analysis for magnesium hydrate supplementation.
    Li J; Wu Y; Chen C; Zhang W; Yue L; Liu T
    Clin Exp Nephrol; 2024 Jan; 28(1):1-12. PubMed ID: 37530867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-induced nephrotoxicity in children: what is the best protective strategy?
    Ruggiero A; Ariano A; Triarico S; Capozza MA; Romano A; Maurizi P; Mastrangelo S; Attinà G
    J Oncol Pharm Pract; 2021 Jan; 27(1):180-186. PubMed ID: 32990190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity.
    Dhillon P; Amir E; Lo M; Kitchlu A; Chan C; Cochlin S; Yip P; Chen E; Lee R; Ng P
    J Oncol Pharm Pract; 2019 Jun; 25(4):875-883. PubMed ID: 29722605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnesium premedication prevents Cisplatin-induced nephrotoxicity in patients with esophageal and hypopharyngeal cancer].
    Hirai S; Kaida S; Ito T; Hasebe S; Ueno M; Udagawa H; Hayashi M
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):743-7. PubMed ID: 23863650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.